Rockefeller Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-200
Closed -$7.18K – 4756
2026
Q1
$7.18K Sell
200
-1,300
-87% -$33.7K ﹤0.01% 4126
2025
Q4
$29.8K Hold
1,500
– – ﹤0.01% 3317
2025
Q3
$27.4K Buy
+1,500
New +$24.7K ﹤0.01% 3193
2023
Q1
– Sell
-1,654
Closed -$27K – 2312
2022
Q4
$27K Hold
1,654
– – ﹤0.01% 2677
2022
Q3
$21K Hold
1,654
– – ﹤0.01% 2742
2022
Q2
$17K Hold
1,654
– – ﹤0.01% 2821
2022
Q1
$22K Hold
1,654
– – ﹤0.01% 2677
2021
Q4
$21K Hold
1,654
– – ﹤0.01% 2622
2021
Q3
$13K Hold
1,654
– – ﹤0.01% 2762
2021
Q2
$11K Hold
1,654
– – ﹤0.01% 2734
2021
Q1
$10K Buy
+1,654
New +$6.91K ﹤0.01% 2576

Other funds holding CLMT

Rockefeller Capital Management's CLMT Position: Q2 2026 in Review

Rockefeller Capital Management sold out of Calumet Specialty Products (CLMT) in Q2 2026, closing a stake of 200 shares — an estimated $7.18K sold.

Rockefeller Capital Management first reported a position in CLMT in Q1 2021 and held it in 11 quarters. The position peaked at $29.8K in Q4 2025. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Rockefeller Capital Management reported no remaining Calumet Specialty Products position as of Q2 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 200 Calumet Specialty Products shares in Q2 2026, an estimated $7.18K.
  • Rockefeller Capital Management first reported a position in Calumet Specialty Products in Q1 2021 and held it in 11 quarters.
  • Rockefeller Capital Management's Calumet Specialty Products position peaked at $29.8K in Q4 2025.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.